COVID-19 vaccination in pediatric cancer patients: A high priority.
作者信息
Charla Yashika, Kalra Manas, Chopra Neha, Choudhury Sangeeta
机构信息
Department of Research, Sir Ganga Ram Hospital, New Delhi, India.
Department of Pediatric Hematology, Oncology and BMT, Sir Ganga Ram Hospital, New Delhi, India.
出版信息
Pediatr Blood Cancer. 2021 Dec;68(12):e29397. doi: 10.1002/pbc.29397. Epub 2021 Oct 11.
Abstract
摘要
相似文献
1
COVID-19 vaccination in pediatric cancer patients: A high priority.儿科癌症患者的新冠病毒疫苗接种：重中之重。
Pediatr Blood Cancer. 2021 Dec;68(12):e29397. doi: 10.1002/pbc.29397. Epub 2021 Oct 11.
2
COVID-19 vaccination for cancer patients: Evidence, priority, and practice.癌症患者的新冠病毒疫苗接种：证据、优先级及实践
Vaccine. 2021 Aug 23;39(36):5075-5077. doi: 10.1016/j.vaccine.2021.07.063. Epub 2021 Jul 24.
3
[COVID-19 vaccination of cancer patients].[癌症患者的新冠病毒疫苗接种]
Tidsskr Nor Laegeforen. 2021 Jan 15;141(3). doi: 10.4045/tidsskr.21.0026. Print 2021 Feb 23.
4
COVID-19 vaccinations for patients with cancer: many remain unvaccinated despite having priority in the vaccine rollout.为癌症患者接种新冠疫苗：尽管在疫苗接种计划中享有优先权，但仍有许多患者未接种。
Intern Med J. 2021 Oct;51(10):1760. doi: 10.1111/imj.15497.
5
COVID-19 vaccination: the VOICE for patients with cancer.2019冠状病毒病疫苗接种：癌症患者的心声
Nat Med. 2021 Apr;27(4):568-569. doi: 10.1038/s41591-021-01240-w.
6
Medical Oncology Group of Australia position statement: COVID-19 vaccination in patients with solid tumours.澳大利亚医学肿瘤学组立场声明：实体瘤患者 COVID-19 疫苗接种。
Intern Med J. 2021 Jun;51(6):955-959. doi: 10.1111/imj.15339.
7
COVID-19 vaccination for children with cancer.为患癌儿童接种新冠疫苗。
Pediatr Blood Cancer. 2022 Feb;69(2):e29340. doi: 10.1002/pbc.29340. Epub 2021 Sep 14.
8
The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate.欧洲肿瘤内科学会关于新冠病毒疫苗接种与癌症患者的行动呼吁：接种疫苗。进行监测。开展教育。
Ann Oncol. 2021 May;32(5):579-581. doi: 10.1016/j.annonc.2021.01.068. Epub 2021 Feb 12.
9
An Open Letter: COVID-19 and Cancer.一封公开信：新冠疫情与癌症
Cancer. 2021 Apr 15;127(8):1171. doi: 10.1002/cncr.33576.
10
COVID-19 Vaccination Outcomes at a Pediatric Long-Term Care Facility.
Pediatr Infect Dis J. 2021 Jul 1;40(7):e281-e283. doi: 10.1097/INF.0000000000003185.
引用本文的文献
1
The Influence of Radioligand Therapy on Immunogenicity Against SARS-CoV-2-A Retrospective Single-Arm Cohort Study of Metastatic Prostate Cancer Patients Receiving PSMA Radioligand Therapy.放射性配体疗法对针对严重急性呼吸综合征冠状病毒2免疫原性的影响——一项接受前列腺特异性膜抗原放射性配体疗法的转移性前列腺癌患者的回顾性单臂队列研究
Cancers (Basel). 2025 Jun 2;17(11):1865. doi: 10.3390/cancers17111865.
2
COVID-19 Vaccine Hesitancy Among Pediatric Oncology and Bone Marrow Transplant Patients.儿科肿瘤学和骨髓移植患者对新冠疫苗的犹豫态度
Vaccines (Basel). 2024 Dec 13;12(12):1407. doi: 10.3390/vaccines12121407.
3
Clinical Outcomes of Pediatric Cancer Patients with COVID-19: A Cross-Sectional Study.新冠肺炎患儿癌症患者的临床结局：一项横断面研究。
Int J Hematol Oncol Stem Cell Res. 2024 Oct 1;18(4):313-322. doi: 10.18502/ijhoscr.v18i4.16756.
4
Safety and Immunogenicity of SARS-CoV-2 Recombinant Spike Protein Vaccine in Children and Adolescents in India: A Phase 2-3 Randomized Clinical Trial.印度儿童和青少年中新冠病毒重组刺突蛋白疫苗的安全性和免疫原性：一项2/3期随机临床试验
JAMA Pediatr. 2023 Jul 31;177(9):911-20. doi: 10.1001/jamapediatrics.2023.2552.
5
Immunologic response, Efficacy, and Safety of Vaccines against COVID-19 Infection in Healthy and immunosuppressed Children and Adolescents Aged 2 - 21 years old: A Systematic Review and Meta-analysis.COVID-19 感染疫苗在 2-21 岁健康和免疫抑制儿童和青少年中的免疫反应、疗效和安全性：系统评价和荟萃分析。
J Clin Virol. 2022 Aug;153:105196. doi: 10.1016/j.jcv.2022.105196. Epub 2022 Jun 3.
本文引用的文献
1
Innate Immunity in Children and the Role of ACE2 Expression in SARS-CoV-2 Infection.儿童的先天免疫以及ACE2表达在SARS-CoV-2感染中的作用
Pediatr Rep. 2021 Jul 2;13(3):363-382. doi: 10.3390/pediatric13030045.
2
Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution.癌症患者对 COVID-19 疫苗的免疫反应：有希望的结果和谨慎的提示。
Cancer Cell. 2021 Aug 9;39(8):1045-1047. doi: 10.1016/j.ccell.2021.07.001. Epub 2021 Jul 3.
3
COVID-19 outcomes in a large pediatric hematology-oncology center in Houston, Texas.德克萨斯州休斯顿一家大型儿科血液肿瘤中心的新冠病毒病（COVID-19）治疗结果
Pediatr Hematol Oncol. 2021 Nov;38(8):695-706. doi: 10.1080/08880018.2021.1924327. Epub 2021 May 25.
4
Clinical Characteristics and Outcomes of COVID-19 in Children in Northern Iran.伊朗北部儿童新冠病毒病的临床特征与转归
Int J Pediatr. 2021 Apr 28;2021:5558287. doi: 10.1155/2021/5558287. eCollection 2021.
6
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).英格兰抗体阳性与抗体阴性医护人员的 SARS-CoV-2 感染率：一项大型、多中心、前瞻性队列研究（SIREN）。
Lancet. 2021 Apr 17;397(10283):1459-1469. doi: 10.1016/S0140-6736(21)00675-9. Epub 2021 Apr 9.
7
Natural mucosal barriers and COVID-19 in children.儿童的天然黏膜屏障与 COVID-19。
JCI Insight. 2021 May 10;6(9):148694. doi: 10.1172/jci.insight.148694.
8
Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors.BNT162b2 mRNA新冠疫苗在接受免疫检查点抑制剂治疗的癌症患者中的短期安全性
Lancet Oncol. 2021 May;22(5):581-583. doi: 10.1016/S1470-2045(21)00155-8. Epub 2021 Apr 1.
9
Clinical presentations and outcomes of children with cancer and COVID-19: A systematic review.儿童癌症与 COVID-19 患者的临床表现和结局：一项系统综述。
Pediatr Blood Cancer. 2021 Jun;68(6):e29005. doi: 10.1002/pbc.29005. Epub 2021 Mar 15.
10
Global effect of the COVID-19 pandemic on paediatric cancer care: a cross-sectional study.COVID-19 大流行对儿科癌症护理的全球影响：一项横断面研究。
Lancet Child Adolesc Health. 2021 May;5(5):332-340. doi: 10.1016/S2352-4642(21)00031-6. Epub 2021 Mar 4.
Zotero 插件